ePro Diary for people with HDV (MACROLIVER)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project within the MACROLIVER initiative aims to develop a digital tool (an electronic patient-reported outcomes diary) for patients with HDV and their caregivers. Adults with confirmed anti-HDV positivity will be asked to use a mobile application to record symptoms, medications, and other relevant health data with informed consent. The study collects real-world patient-reported information to characterize symptom patterns, disease impact, and app usability in routine care. Data are collected at ASST-Papa Giovanni XXIII in Bergamo, Italy, and will inform further tool development and wider implementation strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* Diagnosis of Delta infection (anti-HDV positivity)
* Signed informed consent
* Ability to adequately understand instructions for correctly using mobile device applications.

Exclusion Criteria:

* Refusal or inability to provide informed consent.

Where it's running

• ASST-Papa Giovanni XXIII
  Bergamo, Italy, Italy Recruiting

Study contacts

• Study coordinator: Pietro Giani, BS
• Email: gastroenterologia.liver@asstpg23.it
• Phone: 035 2675134

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding Hepatitis D and its impact on patients

  This study is trying to understand how Hepatitis D affects patients by looking at their backgrounds and health to help create better treatment plans.

  Recruiting at 3 sites Hannover Medical School · Hanover and 3 other locations · NCT06160635

• Larsucosterol for people with severe alcohol-associated hepatitis

  This trial will test whether larsucosterol helps people with severe alcohol-associated hepatitis survive 90 days without needing a liver transplant.

  Recruiting at 37 sites Phase 3 Bausch Health Americas, Inc. · Birmingham, Alabama and 91 other locations · NCT07428538

• Untreated or Unknown HBV, HDV, and HCV in South-East Austria: See if People Need Care

  This study looks at past test results to see how many people in South-East Austria have hepatitis B, hepatitis D coinfection, or hepatitis C that hasn’t been treated yet or isn’t known, and then invites them for care.

  Recruiting Medical University of Graz · Graz, Styra · NCT06834178

• Investigating symptoms and blood test characteristics of acute hepatitis in children

  This study is trying to learn more about the symptoms and blood test results of children with acute hepatitis to help doctors recognize and manage the condition better.

  Recruiting at 2 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna and 1 other locations · NCT06761261

• Comparing two types of ultrasound for patients with viral hepatitis

  This study is testing whether a new ultraportable ultrasound is better than the regular ultrasound for helping patients with viral hepatitis get accurate diagnoses and feel more comfortable during the process.

  Recruiting University of Lausanne Hospitals · Lausanne, Canton of Vaud · NCT06571981

• Low dead-space syringe and needle distribution for people who inject drugs in low- and middle-income countries

  This program will test whether offering low dead-space syringes and needles to people who inject drugs at needle and syringe programs in several low- and middle-income countries increases acceptability and use of safer injecting equipment.

  Recruiting at 9 sites Médecins du Monde · Yerevan and 8 other locations · NCT06395129

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.